Floatz logo

Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer

Pancreatic Neoplasm

Tianjin Medical University Cancer Institute and Hospitalmonoclonal_antibodyPhase 3Active
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
62/ 100
Competitive Position
59/ 100

Competitive context

376 Active assets in the Pancreatic Neoplasm cohort.

Asset / SponsorPhaseRating
Tinzaparin
Helsinki University Central Hospital
Phase 4BBB
Cis-Diamminedichloroplatinum Ii
Taiho Oncology, Inc.
Phase 3BB
Xaliplatin
Memorial Sloan Kettering Cancer Center
Phase 3BB
Fluorouracilum
Memorial Sloan Kettering Cancer Center
Phase 3BB
Capecitabine
Tianjin Medical University Cancer Institute and Hospital
Phase 3BB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, Anti-(Humanized Mouse Monoclonal Hr3 .Beta.1 Chain Anti-Human Epidermal Growth Factor Receptor), Disulfide With Humanized Mouse Monoclonal Hr3 .Kappa.-Chain, Dimer is also rated in:

malignant pancreatic neoplasmActive
BBB
Indicative · Phase 4
76 / 100
View asset →
adult glioblastomaDormant
BB
Indicative · Phase 3
64 / 100
View asset →
non-small cell lung carcinomaDormant
B
Indicative · Phase 2
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →